Terrace Biotech 的專業知識源于 UCSF 醫學中心的肺研究小組，該小組幫助表征了肺表面活性物質，然后開發了一種合成形式，用于治療患有呼吸窘迫綜合征的早產兒。Terrace Biotech 擁有超過 25 年的肺細胞生物學研究經驗，將其專業知識應用于醫學研究的進一步創新和改善人類健康。

Group at UCSF Medical Center that helped characterize pulmonary surfactant and then developed a synthetic form of it that is used to treat premature infants with respiratory distress syndrome. With over twenty-five years of 'hands on' research experience in lung cell biology, Terrace Biotech applies its expertise to further innovation in medical research and improve human health.

Terrace Biotech 生產特異性針對人肺泡1型和2型的胞的特異性抗體。抗體被廣泛應用于：免疫組化、Western Blot,流式細胞分離，細胞分選等。靶點科技現貨庫存，歡迎訂購。背景知識介紹見靶點商城。

產品信息：